|
|
|
Sunday, March 21, 2010 — 7:30 PM, Virginia
|
|
|
Moderator:
|
Barbara A. Zehnbauer, Centers for Disease Control and Prevention, Atlanta, GA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Margaret Gulley is a consultant for Qiagen. The other speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 7:30 | Introduction - Barbara A. Zehnbauer, Centers for Disease Control and Prevention, Atlanta, GA |
| 7:45 | Circulating Tumor Cells: Monitoring Tumor Progression - Barbara A. Zehnbauer, Centers for Disease Control and Prevention, Atlanta, GA |
| 8:20 | Molecular Assessment of Molar Pregnancies - Kathleen M. Murphy, Johns Hopkins Medical Institutions, Baltimore, MD |
| 8:55 | Molecular Assessment of HPV in Patients with Head and Neck Tumors - Jennifer L. Hunt, Massachusetts General Hospital, Boston, MA |
Topics were selected by Barbara A. Zehnbauer on the basis of email dialogue with members of the Association for Molecular Pathology who are also members of the USCAP, initiated b y a posting in the CHAMP listserve, and considering topics previously discussed in this companion meeting.
The topics provide updates for practicing anatomic pathologists on advances in molecular pathology that have implications for the targeted diagnostics of several abnormal tissue types.
The objective is to provide updates on the molecular pathology of various metastatic cancers, molar pregnancies, and human papilloma virus in head and neck tumors that hav implications for the diagnosis and prognosis of these abnormalities.
|
|
|
|
